TR
Trulieve Cannabis Corp.
TRLV · NYSE
$12.46 +8.35% (+$0.96)
1M +11.94%
Market Cap $2.12B
P/E Ratio -
Div. Yield -
ROE 44.05%
Piotroski F-Score Moderate
5/9Valuation
89 /100
Cheap P/S 1.86x
P/FCF 11.33x
P/B 2.76x
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
48 /100
Moderate Gross margin 59.47%
FCF margin 16.40%
Net margin 41.56%
Quality
7 /100
Poor ROIC 19.74%
Asset turnover 0.55x
ROE 44.05%
Debt
68 /100
Low Debt/Equity 0.34x
Int. coverage -4.73x
Current ratio 5.94x
Stability
12 /100
Unstable Beta 1.76x
Rev. volatility N/A
Profitable years N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TRLV
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Kimberly A. Rivers
Employees
5,000
Headquarters
Tallahassee
Prihajajoči dogodki
06 NOV.
Earnings
Upcoming earnings report